91̽»¨

³¢Ã¤²Ô°ì²õ³Ù¾±²µ

Erik Gerner

Forskarstuderande

Avd för biomaterialvetenskap
µþ±ð²õö°ì²õ²¹»å°ù±ð²õ²õ
Arvid Wallgrens backe 20

Om Erik Gerner

AKTUELLT:

Erik Gerner disputerade inom ämnet biomaterialvetenskap, den 9 september 2022

Titeln på hans avhandling är - Role of sodium salicylate as virulence inhibitor for soft tissue infections

Läs en kort populärvetenskaplig sammanfattning om avhandlingen - Nya sätt att behandla och förebygga infektioner i svårläkta sår

FORSKNING:

Erik Gerner holds a master of science in biotechnology and graduated from Chalmers University of Technology in 2011. Since then, Erik has worked at the Gothenburg-based medical device company Mölnlycke Health Care with a focus on developing wound care solutions for infected wounds. Since 2018, Erik pursues PhD studies at the Department of Biomaterials at University 91̽»¨. The industrial PhD project is about finding novel treatment solutions for infected wounds, with a focus on targeting the bacterial communicating system - quorum sensing. The project is co-financed by Mölnlycke and the Swedish foundation for strategic research (SSF) and involves in vitro, ex vivo and in vivo models.

Research website: /en/research/trobos-group

Research interests:

  • Wound infections and imparied wound healing
  • Bacterial pathogenesis and virulence
  • Biofilm formation, visualization
  • Quorum sensing
  • Inflammation
  • in vivo infection models